| Financial Year |
March 31 2023 |
| Monetary Funds |
298,720,530.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,000.00 |
| Accounts Receivable |
55,175,923.98 |
| Advances to Suppliers |
3,602,054.04 |
| Other Receivables |
2,182,848.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
40,104,548.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,110,493.00 |
| Other Current Assets |
1,379,121.84 |
| Total Current Assets |
424,162,217.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
34,282,267.92 |
| Long-term Equity Investment |
-- |
| Investment Properties |
8,814,125.29 |
| Fixed Assetes |
82,053,443.09 |
| Under-construction Projects |
628,420.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,783,089.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,056,466.17 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
153,056,429.25 |
| Total Assets |
577,218,646.62 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,007,296.00 |
| Accounts Payable |
23,814,195.33 |
| Accounts Received In Advance |
830,952.40 |
| Employee Compensation Payable |
3,666,137.82 |
| Taxes Payable |
2,337,530.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,908,151.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
587,443.85 |
| Other Current Liabilities |
12,362.20 |
| Sub-Total of Current Liabilities |
57,582,726.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
190,023.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,217,259.86 |
| Total Liabilities |
58,799,986.12 |
| Paid-In Capital(Or Share Stock) |
303,359,723.00 |
| Capital Surplus |
54,304,493.89 |
| Surplus Reserve |
27,888,897.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
132,865,545.85 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
518,418,660.50 |
| Owner's Equity（Stockholder's Equity） |
518,418,660.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
577,218,646.62 |
